ARTICLE | Company News
CoCensys, Parke-Davis sales and marketing update
July 7, 1997 7:00 AM UTC
COCN will exclusively market Parke-Davis's Zarontin pediatric epilepsy drug to neurologists in the U.S. COCN and Parke-Davis, a division of Warner-Lambert Co. (Morris Plains, N.J.) will share in pr...